GLO1
MOLECULAR TARGETglyoxalase I
GLO1 (glyoxalase I) is targeted by 11 compounds in the BiohacksAI evidence corpus, derived from PubMed bioassay data. Each compound is ranked by confidence score (log-normalized assay count × evidence quality).
Compounds Targeting GLO1
Ranked by bioassay confidence score (PubChem active assay count × evidence quality).
| # | Compound | Confidence | Active Assays |
|---|---|---|---|
| 1 | morin | 4.28 | 71 |
| 2 | bisdemethoxycurcumin | 3.78 | 43 |
| 3 | lapachol | 3.76 | 42 |
| 4 | zopolrestat | 3.04 | 20 |
| 5 | acemetacin | 2.08 | 7 |
| 6 | delphinidin chloride | 1.95 | 6 |
| 7 | cyanidin chloride | 1.95 | 6 |
| 8 | myricetin-3-O-galactopyranoside [Supplementary Concept] | 1.39 | 3 |
| 9 | piceatannol | 1.10 | 2 |
| 10 | Luteolin 5,7,3',4'-tetrahydroxy-flavone, | 0.69 | 1 |
| 11 | Quercetin | 0.69 | 1 |
About GLO1 as a Drug Target
GLO1 (glyoxalase I) is a well-characterized molecular target in biomedical research. BiohacksAI tracks 11 compounds with documented GLO1 interaction from PubChem bioassay data, cross-referenced with PubMed clinical evidence. The confidence score reflects the log-normalized count of active PubChem assays, weighted by evidence quality from the BiohacksAI corpus.
GLO1 inhibitors, activators, and modulators are of interest in research areas including longevity, metabolic health, and neurological function. Each compound profile includes evidence score, RCT count, human study ratio, research velocity, and domain relevance.